Hypertrophic cardiomyopathy (HCM), the most common genetic heart disease, has an estimated prevalence in the general population of 1:500–1:200. The diagnosis is based on the presence of left ventricular hypertrophy (LVH) that is not fully explained by loading conditions, and HCM occurs in the absence of other cardiac, systemic, or metabolic disease or in the context of a multiorgan syndrome associated with LVH. Despite being considered a genetic disease, the initial diagnosis of HCM does not require genetic testing. The […]